Metabolism of ciclesonide in the upper and lower airways: review of available data
Ruediger Nave, Nigel McCrackenNycomed GmbH, Konstanz, GermanyAbstract: Ciclesonide is a novel corticosteroid (CS) for the treatment of asthma and allergic rhinitis. After administration, the parent compound ciclesonide is converted by intracellular airway esterases to its pharmacologically active me...
Main Authors: | Ruediger Nave, Nigel McCracken |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-09-01
|
Series: | Journal of Asthma and Allergy |
Online Access: | http://www.dovepress.com/metabolism-of-ciclesonide-in-the-upper-and-lower-airways-review-of-ava-a2174 |
Similar Items
-
In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices
by: Fisher Robyn, et al.
Published: (2007-09-01) -
Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01) -
From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
by: Nave R, et al.
Published: (2013-03-01) -
Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma
by: Nakaji, Hitoshi
Published: (2013) -
Intranasal ciclesonide for allergic rhinitis
by: Ben Williams, et al.
Published: (2008-11-01)